Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Ensem Therapeutics
Centre Oscar Lambret
IRCCS Azienda Ospedaliero-Universitaria di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna
UMC Utrecht
Hoffmann-La Roche
Pfizer
Tempus AI
Università Cattolica di Milano
Eli Lilly and Company
ViroMissile, Inc.
Hospices Civils de Lyon
Cancer Research UK
Sichuan Enray Pharmaceutical Sciences Company
Pfizer
Duke University
AstraZeneca
Pfizer
Tizona Therapeutics, Inc
The First Affiliated Hospital of Xiamen University
Dana-Farber Cancer Institute
University of California, San Diego
University of Arizona
Wake Forest University Health Sciences
Hospices Civils de Lyon
Adaptimmune
University of California, San Diego
Manchester University NHS Foundation Trust
Georgetown University
University of California, Davis
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
University Health Network, Toronto
University Health Network, Toronto
AgonOx, Inc.
Elephas
M.D. Anderson Cancer Center
Medical University of South Carolina
Eli Lilly and Company
Novartis
Universidad de Granada
Brigham and Women's Hospital
Var2 Pharmaceuticals
Elephas
OncoNano Medicine, Inc.
Institut de Cancérologie de Lorraine
Calico Life Sciences LLC
GlaxoSmithKline
University Hospital, Lille